global messaging alerts

Expert Content Library Webinars

Our technical experts share their knowledge. We pride ourselves in developing customized solutions to achieve your fill-finish and drug delivery challenges.


  • July 5, 2023

    “Revolutionizing Prefilled Injectables through Innovative Technology”
    Learn how scalable fill-finish, a compact supply chain, and cost-efficient manufacturing can solve drug delivery challenges for prefilled injectables.

    As the demand for parenteral products increases, companies are seeking solutions that offer the benefits of prefilled formats while reducing lead times and costs associated with sterile fill-finish services. The projected growth of sterile injectables in the next decade makes finding such solutions crucial. Aseptic manufacturing technology combined with injection molding offers a more flexible and resilient supply chain, even during global crises such as the COVID-19 pandemic.

    In this webinar, a case study will be presented that showcases the advancement of product design based on customer needs, especially in the context of injectables. The study will demonstrate the progression from using multi-dose glass vials to single-dose prefilled injectors, and how this evolution aligns with the future of technology being in plastic. The speakers will emphasize the logical progression with a focus on integrating quality, convenience and safety into innovative technology. The FDA has outlined key considerations for transitioning to innovative combination products which will also be discussed. By following a device development approach, a modular and customizable design can be achieved, offering endless possibilities for creating the appropriate drug delivery solution.

    • Identify critical factors to consider when transitioning from a vial to a combination product and how to navigate the challenges involved in this process
    • Learn about the next-generation advanced aseptic fill & finish technology for prefilled single-dose sterile injectables and its impact on the pharmaceutical industry
    • Explore the history of injectables and the changing demands of customers for enhanced drug delivery systems
    • Discover key considerations when transitioning from vials to combination products and strategies to overcome associated challenges


    • Tony Wasilewski, Vice President, Pharmaceutical Development Services, ApiJect Systems, Corp.
    • Lauren Greenberg, Vice President, Device Development, ApiJect Systems, Corp.
  • December 8, 2021

    Fierce Pharma: “Next Supply Chain Challenge: Syringes”

    An estimated 14 to 19 billion incremental injections will be required by year-end 2022 to vaccinate the world’s population against COVID-19 while supplying related boosters and adjuvants. In response, the industry is shifting billions of syringes from routine vaccinations and therapeutics to COVID, increasing existing capacity, and building new manufacturing sites for syringes. Yet COVID’s supply chain is still expected to fall short. What is the source of this looming shortage? Is “syringe nationalism” causing export embargoes? How is the industry responding? Is it a supply chain problem?

    In this webinar, three experts in pharma and global health discuss potential solutions including,

    • Onshoring of production
    • Increasing capacity in existing plants
    • Investing in new facilities
    • Need for Government funding of long-term supply chain infrastructure
    • Resources and technical know-how required for production
    • Need for trained local personnel to put “shots in arms”


    • Ed Kelley, PhD, Chief Global Health Officer, ApiJect
    • Omair Ahmed, Chief Strategy Officer, Nexus Pharmaceuticals
  • October 15, 2021

    INTERPHEX Live 2021: “Creating a Sustainable Public Health Supply Chain”

    Industry experts share insights on how stakeholders can maintain a robust, resilient supply chain essential to global health and vaccine security, with an accelerated response time to meet the needs of current and future pandemics. The building blocks for this supply chain resiliency include tech transfer, designing for right-size capacity, improving operational efficiencies, implementing state-of-the-art technologies, and establishing regulatory and quality systems.


    •  Ed Kelley, PhD, former Director of Integrated Health Services for WHO and Chief Global Health Officer for ApiJect
    • Rob Roy, PE, Director of Aseptic Technology at IPS-Integrated Project Services
    • Paul Fisher, Director of Process Architecture at IPS-Integrated Project Services
    • Jim Fries, Chief Executive Officer, RX-360
  • October 15, 2021

    INTERPHEX Live 2021 Session: “Pros and Cons of Global Fill-Finish”

    Responding to the COVID-19 pandemic, governments and public health agencies worldwide are developing quality vaccine programs, including local fill-finish capacity, to support global immunization. Yet even before COVID, countries were already facing increased vaccine demand due to population growth. The panel will discuss key challenges and opportunities as governments and pharmaceutical manufacturers seek to establish fill-finish facilities around the world to enable access to greater and more diversified vaccine manufacturing while improving preparedness to respond to future pandemics.


    • Ed Kelley, PhD, former Director of Integrated Health Services for WHO; Chief Global Health Officer,  ApiJect
    • Jason Collins, AIA, Director of Process Architecture, IPS-Integrated Project Services
    • Omair Ahmed, Chief Strategy Officer, Nexus Pharmaceuticals
Social media & sharing icons powered by UltimatelySocial